28.95000 USD
0.07
0.24%
Last update Dec 15, 3:59 PM EST
Market closed
Day range
28.45000
29.49990
Previous close
29.020000
Open
29.20000
Access this stock data via API
Subscribe
Arcutis Biotherapeutics Inc.
28.95
0.07
0.24%

Analysis

Earnings estimate Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Number of analysts 7 3 7 7
Average estimate 0.08 0.03 -0.15 0.45
Low estimate -0.05 -0.02 -0.31 0.25
High estimate 0.17 0.12 0.15 0.78
Last year EPS -0.09 -0.20 -1.16 -0.15
Access /earnings_estimate data via our API — starting from the Ultra plan.
Revenue estimate Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Number of Analysts 6 4 8 8
Avg. estimate 109.83M 98.23M 357.45M 467.32M
Low estimate 107M 94.60M 353.60M 462M
High estimate 112.60M 102.31M 361.30M 470.10M
Last year sales 71.36M 65.85M 196.54M 357.45M
Sales growth 0.54 0.49 0.82 0.31
Access /revenue_estimate data via our API — starting from the Ultra plan.
EPS trend Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Current estimate 0.08 0.03 -0.15 0.45
7 days ago 0.07 0.06 -0.15 0.44
30 days ago -0.02 -0.05 -0.45 0.15
60 days ago -0.02 -0.05 -0.46 0.13
90 days ago -0.02 -0.05 -0.46 0.13
Access /eps_trend data via our API — starting from the Ultra plan.
EPS revisions Current quarter
(Dec 2025)
Next quarter
(Mar 2026)
Current year
(Dec 2025)
Next year
(Dec 2026)
Up last 7 days 1 0 1 1
Up last 30 days 5 0 6 5
Down last 7 days 0 0 0 0
Down last 30 days 2 0 0 0
Access /eps_revisions data via our API — starting from the Ultra plan.
Growth estimates
Current qtr (Dec 2025) 1.841%
Next qtr. (Mar 2026) 1.167%
Current year (2025) 0.871%
Next 5 years (per annum) 2.131%
Past 5 years (per annum) -2.262%
Access /growth_estimates data via our API — starting from the Ultra plan.

Recommendation

Access /recommendations data via our API — starting from the Ultra plan.

Analyst ratings

Firm Date Action
Mizuho Nov 28, 2025 Maintains
Goldman Sachs Oct 30, 2025 Maintains
Needham Oct 28, 2025 Maintains
Needham Aug 07, 2025 Maintains
Goldman Sachs Jul 25, 2025 Initiates
Needham May 23, 2025 Reiterates
Needham Apr 09, 2025 Reiterates
HC Wainwright & Co. Apr 03, 2025 Reiterates
Needham Apr 03, 2025 Reiterates
Guggenheim Apr 03, 2025 Reiterates
Jefferies Mar 11, 2025 Maintains
Goldman Sachs Feb 27, 2025 Maintains
HC Wainwright & Co. Feb 26, 2025 Reiterates
Needham Feb 26, 2025 Reiterates
Mizuho Feb 26, 2025 Maintains
Guggenheim Feb 24, 2025 Reiterates
Guggenheim Feb 10, 2025 Reiterates
HC Wainwright & Co. Jan 13, 2025 Reiterates
Mizuho Jan 07, 2025 Maintains
HC Wainwright & Co. Dec 30, 2024 Initiates
Needham Dec 17, 2024 Maintains
Needham Nov 07, 2024 Reiterates
Jefferies Aug 28, 2024 Initiates
Needham Aug 15, 2024 Reiterates
Needham Jul 30, 2024 Reiterates
Needham Jul 10, 2024 Reiterates
Needham May 15, 2024 Maintains
Mizuho May 15, 2024 Maintains
Needham Apr 12, 2024 Reiterates
Goldman Sachs Feb 28, 2024 Maintains
Access /analyst_ratings/light data via our API — starting from the Ultra plan.
Market closed

Exchange is currently closed
Pre-market opens in 6 hours 50 minutes

21:10
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).